| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-06 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-06 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-06 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-05 |